Carregant...
Miniatura

Tipus de document

Part del llibre

Versió

Versió publicada

Data de publicació

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/103662

The role of the c-Jun N-terminal kinase (JNK) pathway in insulin resistance

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Obesity is usually associated with a decreased response to insulin, a major metabolic defect known as insulin resistance and an early trait in the development of type 2 diabetes. The c-Jun N-terminal kinase (JNK) pathway has emerged as a central regulator of insulin sensitivity, locally and systemically, thereby, of body’s metabolic homeostasis. As the incidence of obesity and type 2 diabetes has alarmingly increased in the last few decades, there is a tremendous necessity to identify novel pharmacological targets to efficiently improve the therapeutic outcome. In this regard, the JNK pathway seems to meet most of the requirements for being an adequate candidate to direct pharmacological intervention.

Descripció

Podeu consultar el llibre complet a: http://hdl.handle.net/2445/103042

Citació

Citació

CAELLES FRANCH, Carme, LANUZA MASDEU, Jordi, ARÉVALO, M. isabel, DÍAZ-DELFÍN, Julieta, MORCILLO, Melisa, BAYOD GIRON, Carles. The role of the c-Jun N-terminal kinase (JNK) pathway in insulin resistance. _Recent Advances in Pharmaceutical Sciences VI_. 2016. Vol. Editors: Diego Muñoz Torrero, núm. Ángeles Manresa Presas, pàgs. 76-90. [consulta: 22 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/103662]

Exportar metadades

JSON - METS

Compartir registre